Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ImmuBless Spray
- Development stage
- Unknown
- Lead developer
- NBM
- Administration
- Oral
01
Overview
ImmuBless Spray is a nutraceutical dietary supplement developed by NatureWise Biotech & Medicals Corporation (NBM). It is formulated as an oral spray containing **PPLs®** (Proprietary-prepared Taiwanese Green Propolis Extract), which is enriched with high concentrations of prenyl flavanones. The product utilizes NBM's proprietary extraction technology to remove debris, contaminants, resin, and wax while concentrating the active components of Taiwanese green propolis. It is marketed for immune support and general health improvement, specifically intended for application to the mouth and throat areas to improve physiological function.
- Brand names
- ImmuBless SprayPPLs ImmuBless Spray
Beyond the preview
Go deeper on ImmuBless Spray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmuBless Spray.